Back to results
US 2003/0216462 A1Published application
(2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors
AssigneeSugen, Inc.
InventorsChung Chen Wei, Peng Cho Tang
Life of this patent
Estimating the term…
Abstract
The present invention relates to (2-oxindol-3-ylidenyl)acetic acid derivatives which modulate the activity of protein kinases and are therefore useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
Claims25
A compound of Formula (I):
- 25
- wherein:
- X is selected from the group consisting of oxygen, sulfur and —NH—;
- Y is selected from the group consisting of carbon and nitrogen, it being understood that, when Y is nitrogen, R5 does not exist;
- n is 0, 1, 2 or 3;
- R1 is selected from the group consisting of hydrogen and alkyl;
- R2 is selected from the group consisting of hydrogen, halo, alkyl, cycloalkyl, aryl, heteroaryl, heteroalicyclic, trihaloalkyl, hydroxy, alkoxy, —C(O)R16, —NR17R18, and —(CH2)rR19;
- R3 and R4 are independently selected from the group consisting of hydrogen, halo, alkyl, trihalomethyl, hydroxy, alkoxy, —NR17R18, —C(O)R16, aryl, 6-member ring heteroaryl, —S(O)2NR17R18, NR17S(O)2R18, —NR17C(O)R18, and —NR17C(O)OR18;
- R5 is selected from the group consisting of hydrogen, alkyl, halo, hydroxy, and alkoxy;
- when n is 0 and X is oxygen or sulfur, R6 is selected from the group consisting of hydrogen, alkyl, and aryl;
- when n is 0 and X is nitrogen, R6 is selected from the group consisting of hydrogen, alkyl, and aryl or R6 combines with X to form a heteroalicyclic ring;
- when n is 1, 2 or 3, R6 is selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, heteroalicyclic, hydroxy, alkoxy, aryloxy, —C(O)R16, and —NR17R18;
- R7 is selected from the group consisting of
- 26
- wherein:
- B1, B2, B3, B4 and B5 are carbon, or
- one of B1, B2, B3, B4 or B5 is nitrogen, the others being carbon, or
- B1 and B2 or B2 and B3 or B3 and B4 are nitrogen, the others being carbon, or
- B1 and B3 or B32 and B4 and B5 are nitrogen, the others being carbon, or
- B1, B3 and B5 are nitrogen, the others being carbon;
- R8, R11 and R12 are independently selected from the group consisting of hydrogen, alkyl, trihalomethyl, hydroxy, alkoxy, halo, —C(O)R16, —(CH2)rR19, and —NR17R18;
- R9 and R10 are independently selected from the group consisting of hydrogen, alkyl, trihalomethyl, hydroxy, alkoxy, halo, —C(O)R16, —(CH2)rR19, and —NR17R18;
- or
- R9 and R10 may combine to form a —(CH2)3— or a —(CH2)4— group;
- it being understood that, when any of B1, B2, B3, B4 or B5 is nitrogen, R8, R9, R10, R11 or R12, respectively, does not exist;
- D1 is selected from the group consisting of —NR20—, oxygen, or sulfur;
- D2, D3 and D4 are independently selected from the group consisting of carbon and nitrogen, it being understood that, when D2, D3 or D4 is nitrogen, R13, R14 or R15, respectively, does not exist;
- R15 is independently selected from-the group consisting of hydrogen, alkyl, alkoxy, halo, —(CH2) R21, and —C(O)R16;
- R13 and R14 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, halo, —(CH2)sR21, and —C(O)R16;
- or
- R13 and R14 may combine to form a —(CH2)4— group;
- R16 is selected from the group consisting of hydrogen, hydroxy, alkoxy, and —NR17R18;
- R17 and R18 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, and heteroaryl;
- or
- R17 and R18 may combine to form a group selected from the group consisting of —(CH2)4—, —(CH2)5—, —(CH2)2O(CH2)2—, and —(CH2)2N(R20)(CH2)2—;
- R19 is selected from the group consisting of hydroxy, alkoxy, —NR17R18, and —C(O)R16, wherein R16, R17 and R18 are defined as above;
- R20 is selected from the group consisting of hydrogen and alkyl;
- R21 is selected from the group consisting of hydroxy, alkoxy, —NR17R18, and —C(O)R16, wherein R16, R17 and R18 are defined as above;
- and,
- r and s are independently 1, 2 or 3;
- or,
- a pharmaceutically acceptable salt thereof.
39 more elements
Dependencies are inferred from the claim text.